In 2020, same day discharge and next day discharge accounted for 22.1 percent (n = 114 of 516) and 63.8 percent (n = 329 of 516) of outpatient TF-TAVR. Samir Kapadia, MD, Chairman of Cardiology, and Amar Krishnaswamy, MD, Head of Interventional Cardiology

Eric Roselli, MD, provides an update on Cleveland Clinic Heart, Vascular and Thoracic Institute Aorta Center's 2022 results.

A Cleveland Clinic-led trial found that testosterone-replacement therapy did not result in a higher incidence of major adverse cardiac events in middle-aged and older men with hypogonadism (also known as low testosterone) who also had preexisting or a hig

Daniel Burns, MD, provides an update on 2022's valve results. Learn more: https://my.clevelandclinic.org/departments/heart/depts/valve-center

Thomas Callahan, MD, electrophysiologist and Co-Director, Lead Extraction Program, discusses the incidence of sudden cardiac death in athletic populations. Dr. Callahan reviews how often SCD occurs in athletes, the etiology and survival, drawing from stud

Aortopathies can have implications for patients w

Cleveland Clinic is dedicated to providing a worl

Life after a cardiac event can be difficult for p

Ayman Hussein, MD, discusses single shot ablation

Pre-participation evaluation is a useful tool for